Breast cancer mucin antigen (BCM) determination by IMX: a preliminary study of epidemiological distribution of the serum levels in gynecological diseases.
Torre
G C
GC
Dept. Obst. Gyn. Hospitals-S. Corona Pietra Ligure.
Barbetti
V
V
Lanfranco
E
E
Robutti
M
M
Foglia
M
M
Corongiu
F
F
Vigliercio
G P
GP
D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor / Q000097:blood*; D001330:Electronic Data Processing; D005260:Female; D005831:Genital Diseases, Female / Q000097:blood* / Q000453:epidemiology; D005833:Genital Neoplasms, Female / Q000097:blood* / Q000453:epidemiology; D006801:Humans; D007124:Immunoenzyme Techniques; D012189:Retrospective Studies; D012680:Sensitivity and Specificity
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; C057387:mucinous carcinoma-associated antigen